Overview: Limitations of Current Treatment of Depression

Maurizio Fava, MD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia

Dost Ongur, MD, PhD

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia

Oliver Freudenreich, MD, FAPM

Assessment and Treatment of Affective Symptoms in Schizophrenia

Oliver Freudenreich, MD, FAPM

Optimal Treatment of Psychosis in Bipolar Disorder

Sharmin Ghaznavi, MD, PhD

Early Detection and Intervention in Bipolar Disorder and Schizophrenia

Andrew A. Nierenberg, MD

Anxiety and Depression: Pharmacological Approaches

Cristina Cusin, MD

Anxiety in the Setting of Depression: Risk, Comorbidity, and Residual Symptoms

Naomi Simon, MD, MSc

Cognitive Dysfunction in Depressed Patients

Andrew Nierenberg, MD

Pharmacotherapeutic Approaches to Fatigue and Depression

David Mischoulon, MD, PhD

Fatigue and Depression: Brain Circuitry, Energy Metabolism

Dan Iosifescu, MD